Evidence-based·Updated November 16, 2026·How we grade evidence

Duloxetine

MedicationSNRI antidepressant (prescription)

Duloxetine is an established SNRI used for both mood and pain. Network meta-analyses found it more effective than placebo for depression and generalized anxiety disorder, and Cochrane reviews found it the best-supported antidepressant for chronic pain, with moderate-quality evidence for diabetic nerve pain. St. John's wort is the critical supplement interaction, heavy alcohol use is a high-severity concern because of liver injury, and saffron is a low one.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with major depression, generalized anxiety disorder, diabetic nerve pain, fibromyalgia or chronic musculoskeletal pain whose prescriber recommends an SNRI

Common dosing range

Set by your prescriber. Labeled doses are 30 to 60 mg once daily for most uses, with a label maximum of 120 mg a day for depression and anxiety and 60 mg a day for the pain conditions

When to expect effects

These are trial lengths, not when benefit starts: diabetic nerve pain results were measured at 12 weeks and fibromyalgia results at 12 and 28 weeks, chronic pain trials averaged 10 weeks, depression trials lasted a median of 8 weeks, and the label's adult anxiety trials lasted 9 to 10 weeks

Watch out for

Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Never combine with MAO inhibitors. Can cause liver injury, worse with heavy drinking. Raises serotonin syndrome risk with St. John's wort and bleeding risk with blood thinners and NSAIDs. Do not stop suddenly: the label recommends a gradual reduction set by your prescriber

What is it

Duloxetine is a prescription medicine of the serotonin and norepinephrine reuptake inhibitor (SNRI) class. It is sold as generic duloxetine delayed-release capsules and under the brand names Cymbalta and Drizalma Sprinkle. The Cymbalta label approves it for major depressive disorder in adults, generalized anxiety disorder in adults and children 7 and older, nerve pain from diabetes (diabetic peripheral neuropathic pain) in adults, fibromyalgia in adults and teens 13 and older, and chronic musculoskeletal pain in adults.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have depression, generalized anxiety disorder, diabetic nerve pain, fibromyalgia or chronic musculoskeletal pain and your prescriber recommends duloxetine
You can keep follow-up visits to check mood, blood pressure, liver health and side effects
You are willing to review every supplement, alcohol habit and over-the-counter medicine with your doctor or pharmacist

Probably skip if…

You take an MAO inhibitor or stopped one in the last 14 days (contraindicated)
You drink heavily or have chronic liver disease or cirrhosis, where the label says not to prescribe it
You have severe kidney disease (eGFR below 30 mL/minute), where the label advises avoiding it
You want to keep taking St. John's wort or other serotonin-boosting supplements without telling your prescriber

Evidence at a glance

major depressive disorder

Good Evidence
Effect
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Best fit
Adults with moderate to severe major depression
Time
Measured over acute treatment trials, typically about 8 weeks

generalized anxiety disorder

Good Evidence
Effect
Modest; about 3 points more improvement on the Hamilton Anxiety Scale than placebo
Best fit
Adult outpatients with generalized anxiety disorder
Time
Measured at the end of the included randomized trials

diabetic peripheral neuropathic pain

Good Evidence
Effect
Moderate; number needed to treat about 5 for halving pain
Best fit
Adults with painful diabetic peripheral neuropathy
Time
Measured at 12 weeks

chronic pain (fibromyalgia, nerve and musculoskeletal pain)

Good Evidence
Effect
Small to moderate; odds of substantial pain relief about 1.9 times placebo
Best fit
Adults with fibromyalgia, neuropathic pain or chronic musculoskeletal pain
Time
Trials averaged about 10 weeks

fibromyalgia

Limited Evidence
Effect
Small; number needed to treat about 8
Best fit
Adults with fibromyalgia
Time
Measured at 12 and 28 weeks

Evidence for 5 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

major depressive disorder

Disease adjunct
Good Evidence

A 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied, including duloxetine, were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. In head-to-head trials, duloxetine was among the drugs with the highest dropout rates. The authors rated the certainty of evidence moderate to very low overall.

Effect size
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Time to effect
Measured over acute treatment trials, typically about 8 weeks
Best fit
Adults with moderate to severe major depression
Less likely
People with bipolar depression, psychotic depression or treatment-resistant depression, who were largely excluded from the trials

Bottom line: Duloxetine works better than placebo for depression, with more dropouts than some alternatives.

generalized anxiety disorder

Disease adjunct
Good Evidence

A 2019 network meta-analysis of 89 randomized trials with 25,441 adult outpatients found duloxetine more effective than placebo for generalized anxiety disorder, lowering the Hamilton Anxiety Scale score by 3.13 points more (95% credible interval 2.13 to 4.13), with relatively good acceptability. Pregabalin, venlafaxine and escitalopram had similar effects.

Effect size
Modest; about 3 points more improvement on the Hamilton Anxiety Scale than placebo
Time to effect
Measured at the end of the included randomized trials
Best fit
Adult outpatients with generalized anxiety disorder
Less likely
People needing long-term evidence, which short trials did not provide

Bottom line: Duloxetine is one of the more effective drugs for generalized anxiety, by a modest margin.

diabetic peripheral neuropathic pain

Disease adjunct
Good Evidence

A 2014 Cochrane review of 8 trials with 2,728 people with painful diabetic neuropathy found duloxetine 60 mg a day made a 50% or greater pain reduction at 12 weeks more likely than placebo (risk ratio 1.73, 95% CI 1.44 to 2.08), with about 1 extra person helped for every 5 treated. The authors rated the evidence moderate quality, noted that the trials were run by the manufacturer, and found doses below 60 mg a day not effective.

Effect size
Moderate; number needed to treat about 5 for halving pain
Time to effect
Measured at 12 weeks
Best fit
Adults with painful diabetic peripheral neuropathy
Less likely
People with central neuropathic pain, where a small trial found no effect

Bottom line: At 60 mg a day, duloxetine halves diabetic nerve pain for about 1 in 5 more people than placebo.

chronic pain (fibromyalgia, nerve and musculoskeletal pain)

Disease adjunct
Good Evidence

A 2023 Cochrane network meta-analysis of 176 trials with 28,664 adults compared 25 antidepressants for chronic pain. Duloxetine was consistently the highest-ranked, and at the standard 60 mg dose it had a small to moderate effect on substantial pain relief (odds ratio 1.91, 95% CI 1.69 to 2.17; moderate-certainty evidence), with high doses no better than standard doses. Trials averaged 10 weeks, mostly excluded people with low mood, and gave no reliable evidence on long-term benefit or safety.

Effect size
Small to moderate; odds of substantial pain relief about 1.9 times placebo
Time to effect
Trials averaged about 10 weeks
Best fit
Adults with fibromyalgia, neuropathic pain or chronic musculoskeletal pain
Less likely
People with headache, which was excluded, or who need proof of long-term benefit

Bottom line: Among antidepressants, duloxetine has the most reliable evidence for chronic pain, with modest effects.

fibromyalgia

Disease adjunct
Limited Evidence

The same Cochrane review pooled 6 fibromyalgia trials with 2,249 participants: duloxetine 60 mg a day made a 50% or greater pain reduction more likely over 12 weeks (risk ratio 1.57, 95% CI 1.20 to 2.06; number needed to treat 8) and over 28 weeks (risk ratio 1.58). The authors rated this lower-quality evidence and said the effect may come partly from improved mental symptoms rather than physical pain.

Effect size
Small; number needed to treat about 8
Time to effect
Measured at 12 and 28 weeks
Best fit
Adults with fibromyalgia
Less likely
People expecting large pain relief, which the trials did not show

Bottom line: Duloxetine helps a minority of people with fibromyalgia, and the evidence is weaker than for nerve pain.

How it works

Duloxetine blocks the reuptake of serotonin and norepinephrine, so these brain and spinal-cord chemical messengers stay active longer. The label says this is thought to explain its effects on mood and on pain signaling, though the exact mechanism is unknown. It is broken down in the liver by the enzymes CYP1A2 and CYP2D6, so drugs that block CYP1A2 can raise its levels: the strong blocker fluvoxamine raised them about 6-fold in a label study. Because it raises serotonin, the main supplement risk is serotonin syndrome when it is combined with other products that do the same, such as St. John's wort or tryptophan. Duloxetine can also injure the liver, which is why the label warns against prescribing it to people with substantial alcohol use or chronic liver disease, and like other serotonin drugs it can make bleeding more likely.

How to take it

1. Typical dose
Your prescriber sets the dose. The Cymbalta label lists: depression 40 to 60 mg a day (as 20 mg twice daily, 30 mg twice daily or 60 mg once daily), maximum 120 mg; generalized anxiety disorder 60 mg once daily for most adults under 65, starting at 30 mg once daily in older adults and in children 7 to 17, maximum 120 mg; diabetic nerve pain 60 mg once daily; fibromyalgia and chronic musculoskeletal pain 30 mg once daily for 1 week, then 60 mg once daily, maximum 60 mg. The label also says there is no evidence that doses above 60 mg a day add benefit for depression or anxiety. The label advises avoiding it in chronic liver disease, cirrhosis and severe kidney impairment.
2. Higher studied dose
The label maximum is 120 mg a day for depression and anxiety, though the label says there is no evidence that doses above 60 mg add benefit. For diabetic nerve pain, a Cochrane review found 60 mg and 120 mg a day effective but lower doses not; the label maximum for the pain conditions is 60 mg, and it says higher doses there are less well tolerated.
3. Timing
Usually once daily at about the same time each day. If you miss a dose, the label says to take it when you remember unless the next dose is almost due, and never take two doses at once.
4. With food
With or without food. The Cymbalta label says to swallow the capsule whole: do not chew or crush it, and do not open it and sprinkle it on food, which can damage its protective coating. Drizalma Sprinkle is a different product with its own instructions, so follow the label of the product you were given.
5. Split dosing
Some depression doses are split as 20 mg or 30 mg twice daily, as your prescriber directs.
6. How long to try
Your prescriber decides how long. Symptoms can occur after abrupt or tapered stopping (dizziness, headache, nausea, irritability, trouble sleeping), so the label recommends a gradual reduction planned with your prescriber.

What to track

Mood changes, new or worse depression, anxiety, agitation or suicidal thoughts, especially early on and after dose changes (contact your provider right away)
Yellow skin or eyes, dark urine, itching or pain in the upper right belly, which can signal liver injury
Dizziness or fainting on standing, especially in the first week and after dose increases
Blood pressure, before starting and periodically during treatment
Unusual bruising or bleeding, especially with aspirin, NSAIDs or a blood thinner
Blood sugar and HbA1c if you have diabetes

Bottom line: Your prescriber sets the dose; swallow the capsule whole, keep alcohol low, and never stop suddenly on your own.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Nausea, dry mouth and constipationSleepiness or tirednessDecreased appetiteIncreased sweating

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Cymbalta label says published data and a postmarketing cohort study have not identified a clear drug-associated risk of major birth defects or other adverse developmental outcomes. Use in the month before delivery may be associated with a higher risk of heavy bleeding after birth, and babies exposed late in the third trimester have had breathing, feeding and temperature problems needing hospital care. Untreated depression and fibromyalgia also carry risks in pregnancy. Breastfeeding: duloxetine passes into breast milk (in 6 women, the estimated infant dose was less than 1% of the maternal dose), and there are reports of sedation, poor feeding and poor weight gain in exposed infants; the label says to weigh the benefits of breastfeeding against the mother's need for treatment and to monitor the infant.

Interactions

St. John's wortCritical

The Cymbalta label lists St. John's wort among serotonergic products that increase the risk of serotonin syndrome, a potentially life-threatening reaction, when combined with duloxetine. Do not combine them without your prescriber's advice, and if you already take both, contact your prescriber rather than stopping anything on your own. Seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

L-tryptophanCritical

The Cymbalta label says combining duloxetine with tryptophan, the amino acid the body turns into serotonin, increases the risk of serotonin syndrome, a potentially life-threatening reaction, and its Medication Guide names over-the-counter tryptophan supplements. No case with only this pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

5-HTP (5-hydroxytryptophan)Critical

5-HTP is the body's direct building block for serotonin, so it adds to duloxetine's serotonin effect. The Cymbalta label names tryptophan, the amino acid the body turns into 5-HTP, among products that increase the risk of serotonin syndrome; it does not name 5-HTP itself, and no duloxetine case has been published. Do not combine them unless your prescriber directs it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

MAO inhibitors (such as phenelzine, tranylcypromine, selegiline, linezolid, intravenous methylene blue)Critical

Contraindicated because of the risk of serotonin syndrome. The label requires at least 14 days after stopping an MAOI before starting duloxetine, and at least 5 days after stopping duloxetine before starting an MAOI.

AlcoholHigh

The label warns that duloxetine with heavy alcohol intake may be associated with severe liver injury, and says it should not be prescribed to people with substantial alcohol use. In a lab study, duloxetine did not worsen alcohol's effects on thinking and coordination; the concern is the liver. Be honest with your prescriber about how much you drink, and report yellow skin or eyes, dark urine or upper-belly pain promptly.

Fluvoxamine, ciprofloxacin and other strong CYP1A2 blockersHigh

The label says to avoid combining duloxetine with potent CYP1A2 inhibitors. Fluvoxamine raised duloxetine exposure about 6-fold in a study, and the label names cimetidine and quinolone antibiotics such as ciprofloxacin as other CYP1A2 blockers. Make sure every prescriber knows you take duloxetine before a new medicine is added.

Aspirin, NSAIDs (ibuprofen, naproxen), warfarin and other blood thinnersHigh

Drugs that affect serotonin reuptake, including duloxetine, can increase bleeding, and the label says NSAIDs, aspirin and anticoagulants may add to this risk; altered warfarin effects, including increased bleeding, have been reported. Ask your pharmacist before using an over-the-counter pain reliever.

Saffron (supplements)Low

Saffron may act partly on serotonin, which raises a theoretical concern about added effects with duloxetine. In an 8-week trial of 160 adults already taking an antidepressant, adding a standardized saffron extract improved clinician-rated depression scores and did not worsen antidepressant side effects; results for duloxetine users were not reported separately. Discuss it with your prescriber before using a saffron supplement.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (4)

+ 5-htp

critical

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Cymbalta label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with duloxetine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, an SSRI.

+ st. john's wort

critical

Duloxetine and St. John's wort both increase serotonergic activity, and combining them can raise serotonin to levels associated with serotonin syndrome, a potentially life-threatening reaction. The duloxetine label lists St. John's Wort among the drugs that raise this risk.

+ tryptophan

critical

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Cymbalta label says combining duloxetine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. No published case with only this pair was found; the rating follows the label warning and matches the rating for tryptophan with venlafaxine, the other SNRI, and with SSRIs such as sertraline and fluoxetine.

+ alcohol

high

Duloxetine (Cymbalta) can occasionally cause liver injury, and liver failure, sometimes fatal, has been reported. Its FDA label says that because duloxetine and alcohol may interact to cause liver injury, it should not be prescribed to people with substantial alcohol use or evidence of chronic liver disease, and that heavy alcohol intake with duloxetine may be associated with severe liver injury. In a study described on the label, duloxetine did not add to alcohol's impairment of thinking and coordination; the concern is the liver.

See all 4 Duloxetine interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic duloxetine, Cymbalta or Drizalma Sprinkle dispensed by a licensed pharmacy on your own prescription
Delayed-release capsules in the strength on your label (Cymbalta comes in 20, 30 and 60 mg)
A Medication Guide with each fill, which explains the suicidality and liver warnings
Instructions to swallow capsules whole and not to stop suddenly

Be skeptical of…

Mood or "serotonin support" supplements containing St. John's wort, tryptophan or 5-HTP presented as safe with antidepressants
Pain or nerve supplements claiming to replace duloxetine, or advice to switch to herbs and stop the medicine
Online sellers offering duloxetine without a prescription
Advice to open capsules or taper yourself off quickly to reduce side effects

Frequently asked questions

Can I take St. John's wort with duloxetine?⌄

This page rates it a critical interaction. The Cymbalta label lists St. John's wort among products that raise the risk of serotonin syndrome with duloxetine. Talk to your prescriber before using it, and if you have been combining them, contact your prescriber rather than stopping anything on your own.

Can I drink alcohol while taking duloxetine?⌄

This page rates heavy drinking with duloxetine a high-severity interaction. The label warns that duloxetine with heavy alcohol intake may be associated with severe liver injury and says it should not be prescribed to people with substantial alcohol use. Be honest with your prescriber about how much you drink.

Is saffron safe with duloxetine?⌄

The concern is theoretical. In a trial of adults already on antidepressants, adding saffron did not worsen side effects, but duloxetine users were not reported separately. This page rates it low severity. Ask your prescriber before starting a saffron supplement.

Can I take ibuprofen with duloxetine?⌄

The label says NSAIDs such as ibuprofen and naproxen, aspirin and blood thinners may add to duloxetine's bleeding risk. Ask your pharmacist before using an over-the-counter pain reliever, especially if you take it often.

Can I open the capsule and mix it with food?⌄

Not for Cymbalta or generic duloxetine capsules. The label says to swallow them whole and not to chew, crush or sprinkle the contents on food, which can damage the coating. If swallowing is hard, ask your prescriber or pharmacist about options.

What happens if I stop duloxetine suddenly?⌄

Stopping can cause symptoms such as dizziness, headache, nausea, irritability and trouble sleeping. The label recommends a gradual reduction rather than stopping abruptly. Talk to your prescriber before making any change.

References by claim

major depressive disorder

Cipriani et al., 2018 · PMC (2018) link

generalized anxiety disorder

Slee et al., 2019 · PubMed (2019) link

diabetic peripheral neuropathic pain

Lunn et al., 2014 · PMC (2014) link

chronic pain (fibromyalgia, nerve and musculoskeletal pain)

Birkinshaw et al., 2023 · PMC (2023) link

Safety

Cymbalta (duloxetine delayed-release capsules) prescribing information · DailyMed (FDA label) link

Interaction: 5-HTP (5-hydroxytryptophan)

Patel et al., 2017 · PMC (2017) link

Interaction: Saffron (supplements)

Lopresti et al., 2019 · PubMed (2019) link

Track Duloxetine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.